<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cardiac effects of chemotherapeutic regimens using high doses of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (180 mg/kg over four days) were assessed in 32 patients with hematologic malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Left ventricular systolic function, determined by the fractional shortening on echocardiogram, declined substantially five to 16 days after the initiation of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Although <z:hpo ids='HP_0001698'>pericardial effusion</z:hpo> on echocardiogram occurred in 33% of the patients studied, ECG voltage decreased five to 14 days after beginning <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> therapy even in those patients without <z:hpo ids='HP_0001698'>pericardial effusion</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001635'>Congestive heart failure</z:hpo> was noted in nine patients (28%) within three weeks of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> administration </plain></SENT>
<SENT sid="4" pm="."><plain>Six of these patients (19%) died of <z:e sem="disease" ids="C0018801" disease_type="Disease or Syndrome" abbrv="">myocardial failure</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0007177" disease_type="Disease or Syndrome" abbrv="">Pericardial tamponade</z:e> occurred in six patients (19%), including five who died of <z:e sem="disease" ids="C0018801" disease_type="Disease or Syndrome" abbrv="">myocardial failure</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Histopathologic and electron microscopic findings showed endothelial injury and a hemorrhagic <z:e sem="disease" ids="C0854532" disease_type="Disease or Syndrome" abbrv="">myopericarditis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> in this high dose is associated with a toxic, often fatal, pericardiomyopathy </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000716'>Depression</z:hpo> of ECG voltage and systolic left ventricular function, though common, do not necessarily predict clinical cardiac deterioration </plain></SENT>
</text></document>